Ipca Labs Q3 Profit Surges 67% to Rs 180 Cr
Ipca Laboratories reported a 67% jump in consolidated net profit to Rs 180 crore for the third quarter ended December 31, 2023. Revenue also increased significantly.
New Delhi, Feb 14 (PTI) Ipca Laboratories on Wednesday reported 67 per cent increase in consolidated net profit at Rs 180 crore for the third quarter ended December 31, 2023.
The drugmaker had reported a net profit of Rs 108 crore for October-December FY23.
Revenue from operations rose to Rs 2,053 crore from Rs 1,546 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.
Shares of the company were trading 0.86 per cent down at Rs 1,150.15 apiece on the BSE.
The drugmaker had reported a net profit of Rs 108 crore for October-December FY23.
Revenue from operations rose to Rs 2,053 crore from Rs 1,546 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.
Shares of the company were trading 0.86 per cent down at Rs 1,150.15 apiece on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Alstone Textiles
- 0.34 ( -2.86)
- 69035259
- Vodafone Idea L
- 9.51 ( -1.04)
- 42462303
- Sunshine Capital
- 0.29 (+ 3.57)
- 38378420
- Welcure Drugs &
- 0.57 (+ 3.64)
- 31697110
- Standard Capital
- 0.64 (+ 1.59)
- 26548715
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback